A phase I pilot study of Triapine [OCX 0191] and cytarabine in patients with hematologic malignancies
Phase of Trial: Phase I
Latest Information Update: 15 Jul 2013
At a glance
- Drugs Cytarabine; OCX 191
- Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Chronic myelomonocytic leukaemia; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 22 Sep 2005 New trial record.